The aim of this study was to determine the seroprevalence anti-hepatitis C virus (HCV)
antibodies and risk factors associated with patients attending primary-care clinics in the …

BACKGROUND: To assess the prevalence of hepatitis C virus (HCV) infection in a general
population and to identify risk factors for acquiring infection. POBLATION AND METHODS: A …

Objective. To report the prevalence of antibodies against the hepatitis C virus (anti-HCV) in a
group of patients with hepatic cirrhosis (HC). Material and Methods. A prospective …

The objective of this study was to investigate the prevalence of antibodies against the
hepatitis C virus (anti‐HCV) and the associated risk factors in a representative sample of the …

Background. Approximately 180 million persons (∼ 2.8%) globally are estimated to be
infected by hepatitis C virus (HCV). HCV prevalence in Mexico has been estimated to be …

AIM: To determine the prevalence of hepatitis C virus (HCV) infection and to study
associated risk factors in the general population of the province of Zamora. PATIENTS AND …

Background: The prevalence of reactive tests to anti-hepatitis C virus (HCV) antibodies in
Mexico is unknown, though estimated to be 1%. There is no single nation-wide study or …

The prevalence in Peru of antibody to hepatitis C virus (anti‐HCV) was determined in a
survey of populations living in the northern jungle region and in groups at high risk of …

Very little is known about the distribution of hepatitis C virus (HCV) within South America. To
assess the exposure of the general population to this virus, a number of sera obtained from …

Hepatitis C virus (HCV) infection has an estimated prevalence of 3% around the world.
Unfortunately, many persons with HCV infection are asymptomatic. The aim of this study was …